MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

Search

ICU Medical Inc

Atvērts

SektorsVeselības aprūpe

124.42 4.7

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

119.11

Max

123.32

Galvenie mērījumi

By Trading Economics

Ienākumi

51M

35M

Pārdošana

-56M

549M

Peļņas marža

6.438

Darbinieki

15,000

EBITDA

94M

106M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+37.65% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 11. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-268M

2.9B

Iepriekšējā atvēršanas cena

119.72

Iepriekšējā slēgšanas cena

124.42

Ziņu noskaņojums

By Acuity

50%

50%

149 / 371 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bullish Evidence

ICU Medical Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 2. okt. 23:30 UTC

Karstas akcijas

Stocks to Watch: Rumble, Applied Materials, American Outdoor Brands

2025. g. 2. okt. 21:21 UTC

Peļņas

Applied Materials Expects New Export Rule to Hit 2026 Revenue by $600 Million

2025. g. 3. okt. 00:00 UTC

Iegādes, apvienošanās, pārņemšana

Warren Buffett's Berkshire Comes to the Aid of Occidental Petroleum -- Again -- WSJ

2025. g. 2. okt. 23:40 UTC

Tirgus saruna

Gold Edges Higher, Aided by Risks U.S. Shutdown May Weaken Economy -- Market Talk

2025. g. 2. okt. 23:39 UTC

Tirgus saruna

Japanese Stocks May Edge Higher, Tracking Wall Street Gains -- Market Talk

2025. g. 2. okt. 23:29 UTC

Iegādes, apvienošanās, pārņemšana

Vistra: Transaction Remains on Track to Close This Qtr or 1Q 2026 >VST

2025. g. 2. okt. 23:29 UTC

Iegādes, apvienošanās, pārņemšana

Vistra: Received Regulatory Approval From FERC for Acquisition of Certain Subsidiaries Owning Seven Natural-Gas Generation Facilities From Lotus Infrastructure Partners >VST

2025. g. 2. okt. 23:29 UTC

Iegādes, apvienošanās, pārņemšana

Vistra: Next Step in Acquisition of Gas Generation Fleet With Approval From Federal Energy Regulatory Commission

2025. g. 2. okt. 23:00 UTC

Tirgus saruna

Warehouse Needs Time to Restore Credibility With Investors -- Market Talk

2025. g. 2. okt. 22:54 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Scales's JV Buyout Lauded by Bull -- Market Talk

2025. g. 2. okt. 22:54 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 2. okt. 22:46 UTC

Tirgus saruna

Synlait Milk Loses Bear Following Sale of North Island Assets -- Market Talk

2025. g. 2. okt. 22:46 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 2. okt. 21:17 UTC

Iegādes, apvienošanās, pārņemšana

Buffett Scores Win in Berkshire's Deal for Occidental Chemicals Unit -- Barrons.com

2025. g. 2. okt. 20:50 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Energy & Utilities Roundup: Market Talk

2025. g. 2. okt. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 2. okt. 20:49 UTC

Iegādes, apvienošanās, pārņemšana

OpenAI's Latest Funding Deal Returns Focus to AI Economy, Lifting U.S. Stocks -- WSJ

2025. g. 2. okt. 20:00 UTC

Iegādes, apvienošanās, pārņemšana

Legrand Signs Definitive Agreement To Acquire Avtron Power Solutions, A Global Provider Of Load Banks & Power Quality Solutions >LR.FR

2025. g. 2. okt. 19:20 UTC

Tirgus saruna

Natural Gas Snaps Winning Streak Despite Small Inventory Rise -- Market Talk

2025. g. 2. okt. 19:10 UTC

Tirgus saruna

Bank of Canada to Publish Inflation Dashboard in 2026 -- Market Talk

2025. g. 2. okt. 19:04 UTC

Tirgus saruna

Oil Futures Extend Losses as Markets Brace for Higher Output -- Market Talk

2025. g. 2. okt. 18:46 UTC

Iegādes, apvienošanās, pārņemšana

Honeywell: Transaction Expected to Improve Annual Free Cash Flow by More Than $100 M Over Next Several Years and Then Decrease Over Time >HON

2025. g. 2. okt. 18:46 UTC

Iegādes, apvienošanās, pārņemšana

Honeywell: Loss Will Be Excluded From Adjusted EPS >HON

2025. g. 2. okt. 18:46 UTC

Iegādes, apvienošanās, pārņemšana

Honeywell: Estimated Impact of Divestiture Will Be One-Time Loss of About $115 M >HON

2025. g. 2. okt. 18:45 UTC

Iegādes, apvienošanās, pārņemšana

Honeywell Will Have No Further Fincl Exposure to the Transferred Liabilities >HON

2025. g. 2. okt. 18:45 UTC

Iegādes, apvienošanās, pārņemšana

Honeywell Utilized Portion of Cash From Resideo Indemnification and Reimbursement Agreement Termination to Fund Delticus Transaction >HON

2025. g. 2. okt. 18:44 UTC

Iegādes, apvienošanās, pārņemšana

Honeywell: Delticus Assumed Full Responsibility for Administering and Resolving All Current and Future Asbestos-Related Claims >HON

2025. g. 2. okt. 18:44 UTC

Iegādes, apvienošanās, pārņemšana

Honeywell and Delticus Contributed About $1.68 B in Cash, as Well as Certain Insurance Assets Related to Legacy Asbestos Liabilities >HON

2025. g. 2. okt. 18:44 UTC

Iegādes, apvienošanās, pārņemšana

Honeywell: Transaction Strengthens Annual Free Cash Flow Generation >HON

2025. g. 2. okt. 18:43 UTC

Iegādes, apvienošanās, pārņemšana

Honeywell Divested All Legacy Bendix Asbestos Liabilities, as Well as Certain Non-Bendix Asbestos Liabilities, to Delticus >HON

Salīdzinājums

Cenas izmaiņa

ICU Medical Inc Prognoze

Cenas mērķis

By TipRanks

37.65% augšup

Prognoze 12 mēnešiem

Vidējais 166.5 USD  37.65%

Augstākais 180 USD

Zemākais 153 USD

Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi ICU Medical Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

3 ratings

2

Pirkt

1

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

137.16 / N/AAtbalsts un pretestība

Īstermiņā

Very Strong Bullish Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

Strong Bearish Evidence

Noskaņojums

By Acuity

149 / 371 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par ICU Medical Inc

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
help-icon Live chat